Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Platelet Rich Plasma for Refractory Dry Eye After Autologous Serum
TCTR20201020002Phase 3Recruiting
- Sponsor
- Ratchadaphiseksomphot Endowment Fund
- Start
- Oct 2020
- Modality
- Adoptive Cell Transfer → Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of autologous platelet-rich plasma in dry eye syndrome (DED), sponsored by Ratchadaphiseksomphot Endowment Fund. Started Oct 2020; status: recruiting.
02
Drugs
autologous platelet-rich plasma
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on TCTR20201020002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20201020002.